• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Canadian Cardiovascular Society Consensus Conference update on cardiac transplantation 2008: Executive Summary.

作者信息

Haddad H, Isaac D, Legare J F, Pflugfelder P, Hendry P, Chan M, Cantin B, Giannetti N, Zieroth S, White M, Warnica W, Doucette K, Rao V, Dipchand A, Cantarovich M, Kostuk W, Cecere R, Charbonneau E, Ross H, Poirier N

机构信息

University of Ottawa Heart Institute, Ottawa, Canada.

出版信息

Can J Cardiol. 2009 Apr;25(4):197-205. doi: 10.1016/s0828-282x(09)70061-3.

DOI:10.1016/s0828-282x(09)70061-3
PMID:19340342
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2706756/
Abstract
摘要

相似文献

1
Canadian Cardiovascular Society Consensus Conference update on cardiac transplantation 2008: Executive Summary.加拿大心血管学会2008年心脏移植共识会议更新：执行摘要。
Can J Cardiol. 2009 Apr;25(4):197-205. doi: 10.1016/s0828-282x(09)70061-3.
2
Medium-term outcome of tacrolimus immunosuppression following rejection or graft dysfunction in heart transplant patients.心脏移植患者发生排斥反应或移植物功能障碍后他克莫司免疫抑制的中期结果。
Transplant Proc. 1998 Jun;30(4):1134-5. doi: 10.1016/s0041-1345(98)00182-1.
3
Antilymphocyte-antibody prophylaxis: review of the adult experience in heart transplantation.抗淋巴细胞抗体预防：心脏移植成人经验综述
Transplant Proc. 1997 Dec;29(8A):13S-15S. doi: 10.1016/s0041-1345(97)00849-x.
4
Long-term outcome with the use of OKT3 induction therapy in heart transplant patients: a single-center experience.心脏移植患者使用OKT3诱导疗法的长期疗效：单中心经验
Transplant Proc. 1998 Jun;30(4):1107-9. doi: 10.1016/s0041-1345(98)00171-7.
5
Induction of immunosuppression with OKT3 following heart transplantation: kidney function as a criterion for control of protocol duration.心脏移植后使用OKT3诱导免疫抑制：以肾功能作为控制方案持续时间的标准。
Transplant Proc. 1999 Sep;31(6):2517-8. doi: 10.1016/s0041-1345(99)00443-1.
6
Grade 2 cellular heart rejection: does it exist?: Yes!
J Heart Lung Transplant. 1995 Jul-Aug;14(4):800-1.
7
Recipient selection algorithm for immunosuppression in cardiac transplantation: OKT3 vs triple therapy alone.心脏移植免疫抑制的受体选择算法：OKT3与单纯三联疗法的比较
Transplant Proc. 1992 Feb;24(1):167-8.
8
Critical evaluation of the association of acute with chronic graft rejection in kidney and heart transplant recipients. The Collaborative Transplant Study.肾移植和心脏移植受者急性与慢性移植排斥反应关联的批判性评估。协作移植研究。
Transplant Proc. 1997 Feb-Mar;29(1-2):73-6. doi: 10.1016/s0041-1345(96)00013-9.
9
Benefits of photopheresis in the treatment of heart transplant patients with multiple/refractory rejection.光分离置换法在治疗心脏移植后发生多次/难治性排斥反应患者中的益处。
Transplant Proc. 1997 Feb-Mar;29(1-2):609-11. doi: 10.1016/s0041-1345(96)00323-5.
10
Early cyclosporine blood levels impact the incidence of acute rejection and overall mortality in the first year after heart transplantation.早期环孢素血药浓度影响心脏移植术后第一年急性排斥反应的发生率和总体死亡率。
Transplant Proc. 1998 Aug;30(5):1671-2. doi: 10.1016/s0041-1345(98)00386-8.

引用本文的文献

1
National Trends of Gender Disparity in Canadian Cardiovascular Society Guideline Authors, 2001-2020.2001 - 2020年加拿大心血管学会指南作者性别差异的全国趋势
CJC Open. 2021 Apr 10;3(12 Suppl):S12-S18. doi: 10.1016/j.cjco.2021.04.003. eCollection 2021 Dec.
2
The Human Explanted Heart Program: A translational bridge for cardiovascular medicine.人类心脏移植项目：心血管医学的转化桥梁。
Biochim Biophys Acta Mol Basis Dis. 2021 Jan 1;1867(1):165995. doi: 10.1016/j.bbadis.2020.165995. Epub 2020 Oct 22.
3
Urinary proteomic signatures associated with β-blockade and heart rate in heart transplant recipients.与β受体阻滞剂和心脏移植受者心率相关的尿蛋白质组学特征。
PLoS One. 2018 Sep 24;13(9):e0204439. doi: 10.1371/journal.pone.0204439. eCollection 2018.
4
Outcomes of Induction Therapy with Rabbit Anti-Thymocyte Globulin in Heart Transplant Recipients: A Single Center Retrospective Cohort Study.兔抗胸腺细胞球蛋白诱导治疗心脏移植受者的疗效：一项单中心回顾性队列研究
Ann Transplant. 2018 Jun 19;23:422-426. doi: 10.12659/AOT.907984.
5
Biomarkers to Assess Right Heart Pressures in Recipients of a Heart Transplant: A Proof-of-Concept Study.评估心脏移植受者右心压力的生物标志物：一项概念验证研究。
Transplant Direct. 2018 Apr 23;4(5):e346. doi: 10.1097/TXD.0000000000000783. eCollection 2018 May.
6
[Hemodynamic interplay between tricuspid valve and right ventricle].[三尖瓣与右心室之间的血流动力学相互作用]
Herz. 2017 Nov;42(7):622-628. doi: 10.1007/s00059-017-4614-x.
7
Urinary Proteomics in Predicting Heart Transplantation Outcomes (uPROPHET)-Rationale and database description.尿蛋白质组学预测心脏移植结局（uPROPHET）——原理与数据库描述
PLoS One. 2017 Sep 7;12(9):e0184443. doi: 10.1371/journal.pone.0184443. eCollection 2017.
8
Clinical and gender differences in heart transplant recipients in the NEW HEART study.“新心脏”研究中心脏移植受者的临床及性别差异
Eur J Cardiovasc Nurs. 2017 Mar;16(3):222-229. doi: 10.1177/1474515116651178. Epub 2016 Jul 8.
9
An Internet-Based Counseling Intervention With Email Reminders that Promotes Self-Care in Adults With Chronic Heart Failure: Randomized Controlled Trial Protocol.一项基于互联网的咨询干预措施，通过电子邮件提醒促进慢性心力衰竭成人的自我护理：随机对照试验方案。
JMIR Res Protoc. 2014 Jan 30;3(1):e5. doi: 10.2196/resprot.2957.

本文引用的文献

1
Registry of the International Society for Heart and Lung Transplantation: a quarter century of thoracic transplantation.国际心肺移植学会登记处：胸外科移植的四分之一个世纪
J Heart Lung Transplant. 2008 Sep;27(9):937-42. doi: 10.1016/j.healun.2008.07.019.
2
Conversion to sirolimus as primary immunosuppression attenuates the progression of allograft vasculopathy after cardiac transplantation.转换为西罗莫司作为主要免疫抑制剂可减轻心脏移植后同种异体移植血管病变的进展。
Circulation. 2007 Dec 4;116(23):2726-33. doi: 10.1161/CIRCULATIONAHA.107.692996. Epub 2007 Nov 19.
3
Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult heart transplant report--2007.国际心肺移植学会登记处：2007年第24份成人心脏移植官方报告
J Heart Lung Transplant. 2007 Aug;26(8):769-81. doi: 10.1016/j.healun.2007.06.004.
4
Lower risk of infectious deaths in cardiac transplant patients receiving basiliximab versus anti-thymocyte globulin as induction therapy.与接受抗胸腺细胞球蛋白作为诱导治疗相比，接受巴利昔单抗的心脏移植患者感染性死亡风险更低。
J Heart Lung Transplant. 2007 Jul;26(7):693-9. doi: 10.1016/j.healun.2007.05.002.
5
Repeat organ transplantation in the United States, 1996-2005.1996 - 2005年美国的重复器官移植
Am J Transplant. 2007;7(5 Pt 2):1424-33. doi: 10.1111/j.1600-6143.2007.01786.x.
6
Comparison of the diagnostic accuracy of brain natriuretic peptide (BNP) and the N-terminal part of the propeptide of BNP immunoassays in chronic and acute heart failure: a systematic review.脑钠肽（BNP）与BNP前体肽N端免疫测定法在慢性和急性心力衰竭中的诊断准确性比较：一项系统评价
Clin Chem. 2007 May;53(5):813-22. doi: 10.1373/clinchem.2006.075713. Epub 2007 Mar 23.
7
Chronic sildenafil lowers transpulmonary gradient and improves cardiac output allowing successful heart transplantation.长期使用西地那非可降低跨肺压差并改善心输出量，从而使心脏移植成功。
Eur J Heart Fail. 2007 Jun-Jul;9(6-7):674-7. doi: 10.1016/j.ejheart.2007.01.008. Epub 2007 Mar 7.
8
Basiliximab and rabbit anti-thymocyte globulin for prophylaxis of acute rejection after heart transplantation: a non-inferiority trial.巴利昔单抗和兔抗胸腺细胞球蛋白预防心脏移植术后急性排斥反应：一项非劣效性试验。
J Heart Lung Transplant. 2007 Mar;26(3):258-63. doi: 10.1016/j.healun.2007.01.006.
9
Induction therapy in heart transplantation: is there a role?心脏移植中的诱导治疗：是否有作用？
J Heart Lung Transplant. 2007 Mar;26(3):205-9. doi: 10.1016/j.healun.2007.01.002.
10
Basiliximab versus rabbit anti-thymocyte globulin for induction therapy in patients after heart transplantation.巴利昔单抗与兔抗胸腺细胞球蛋白用于心脏移植术后患者诱导治疗的比较。
J Heart Lung Transplant. 2006 Nov;25(11):1358-62. doi: 10.1016/j.healun.2006.09.002.